Immunomodulatory effect of mesenchymal stem cells: Cell origin and cell quality variations

  • Marwa El-SayedEmail author
  • Mohamed Ali El-Feky
  • Mostafa I. El-Amir
  • Al Shaimaa Hasan
  • Mohammed Tag-Adeen
  • Yoshishige Urata
  • Shinji Goto
  • Lan Luo
  • Chen Yan
  • Tao-Sheng Li
Original Article


The immunomodulatory property of mesenchymal stem cells (MSCs) has been previously reported. Still it is unclear if this property can be affected by the cell origin and cell quality. Using primary MSCs expanded from bone marrow (BM-MSCs) and adipose tissue (AD-MSCs) of mice, we investigated whether the immunomodulatory property of MSCs varied with cell origin and cell quality (early- vs. late-passaged BM-MSCs). BM-MSCs (p1) and AD-MSCs (p1) had a typical spindle shape, but morphological changes were observed in late-passaged BM-MSCs (p6). A pathway-focused array showed that the expression of chemokine/cytokine genes varied with different cell origins and qualities. By co-culturing with spleen mononuclear cells (MNC) for 3 days, the expression of CD4 was suppressed by all types of MSCs. By contrast, the expression of CD8 was suppressed by BM-MSCs and increased by AD-MSCs. The expression ratio of CD206 to CD86 was at a comparable level after co-culture with AD-MSCs and BM-MSCs, but was lower with late-passaged BM-MSCs. AD-MSCs highly induced the release of IL6, IL-10 and TGF-β in culture medium. Compared with early-passaged BM-MSCs (p1), late-passaged BM-MSCs (p6) released less TGF-β. Our data suggests that the immunomodulatory properties of MSCs vary with cell origin and cell quality and that BM-MSCs of good quality are likely the optimal source of immunomodulation.


Mesenchymal stem cell BM-MSC AD-MSC Immunomodulation T cell Macrophage 



This study was supported by the Ministry of Higher Education, Egypt and a Grant-in-Aid from the Ministry of Education, Science, Sports, Culture and Technology, Japan.

Compliance with ethical standards

Competing interests

The authors declare that they have no competing interests.

Ethics approval

All experiments were approved by the Institutional Animal Care and Use Committee of Nagasaki University and performed in accordance with the institutional and national guidelines.

Supplementary material

11033_2018_4582_MOESM1_ESM.doc (5.7 mb)
Supplementary material 1 (DOC 5881 KB)


  1. 1.
    Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guina-pig bone marrow and spleen cells. Cell Prolif 3:393–403CrossRefGoogle Scholar
  2. 2.
    Pittenger MF (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147CrossRefGoogle Scholar
  3. 3.
    Gao F, Chiu SM, Motan DA et al (2016) Mesenchymal stem cells and immunomodulation: status and prospects. Cell Death Dis. Google Scholar
  4. 4.
    Abreu SC, Antunes MA, Xisto DG et al (2017) Bone marrow, adipose, and lung tissue-derived murine mesenchymal stromal cells release different mediators and differentially affect airway and lung parenchyma in experimental asthma. Stem Cells Transl Med. Google Scholar
  5. 5.
    Wen L, Zhu M, Madigan MC et al (2014) Immunomodulatory effects of bone marrow-derived mesenchymal stem cells on pro-inflammatory cytokine-stimulated human corneal epithelial cells. PLoS ONE. Google Scholar
  6. 6.
    Tomic S, Djokic J, Vasilijic S, Vucevic D et al (2011) Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists. Stem Cells Dev. Google Scholar
  7. 7.
    Amable PR, Teixeira MV, Carias RB et al (2014) Gene expression and protein secretion during human mesenchymal cell differentiation into adipogenic cells. BMC Cell Biol 15:46CrossRefGoogle Scholar
  8. 8.
    Engela AU, Baan CC, Dor FJ et al (2012) On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation. Front Immunol. Google Scholar
  9. 9.
    Kyurkchiev D, Bochev I, Ivanova-Todorova E, Mourdjeva M et al (2014) Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells. Google Scholar
  10. 10.
    Anjos-Afonso F, Bonnet D (2011) Prospective identification and isolation of murine bone marrow derived multipotent mesenchymal progenitor cells. Best Pract Res Clin Haematol. Google Scholar
  11. 11.
    Zhang L, Chan C (2010) Isolation and enrichment of rat mesenchymal stem cells (MSCs) and separation of single-colony derived MSCs. J Vis Exp. Google Scholar
  12. 12.
    Huang S, Xu L, Sun Y, Wu T et al (2015) An improved protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. J Orthop Transl. Google Scholar
  13. 13.
    Yu G, Wu X, Kilroy G, Halvorsen YD et al (2011) Isolation of murine adipose-derived stem cells. Methods Mol Biol. CrossRefGoogle Scholar
  14. 14.
    Ellis KM, O’Carroll DC, Lewis MD et al (2014) Neurogenic potential of dental pulp stem cells isolated from murine incisors. Stem Cell Res Ther. Google Scholar
  15. 15.
    Lushaj EB, Anstadt E, Haworth R et al (2011) Mesenchymal stromal cells are present in the heart and promote growth of adult stem cells in vitro. Cytotherapy. Google Scholar
  16. 16.
    Kang SG, Shinojima N, Hossain A et al (2010) Isolation and perivascular localization of mesenchymal stem cells from mouse brain. Neurosurgery. Google Scholar
  17. 17.
    Strioga M, Viswanathan S, Darinskas A et al (2012) Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev. Google Scholar
  18. 18.
    Glennie S, Soeiro I, Dyson PJ et al (2005) Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood. Google Scholar
  19. 19.
    Bach M, Schimmelpfennig C, Stolzing A (2014) Influence of murine mesenchymal stem cells on proliferation, phenotype, vitality, and cytotoxicity of murine cytokine-induced killer cells in coculture. PLoS ONE. Google Scholar
  20. 20.
    Kudlik G, Hegyi B, Czibula A et al (2016) Mesenchymal stem cells promote macrophage polarization toward M2b-like cells. Exp Cell Res. Google Scholar
  21. 21.
    Zhou Y, Day A, Haykal S et al (2013) Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway. Cytotherapy.
  22. 22.
    Ribeiro A, Laranjeira P, Mendes S et al (2013) Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Stem Cell Res Ther. Google Scholar
  23. 23.
    Le Blanc K, Rasmusson I, Sundberg B et al (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. Google Scholar
  24. 24.
    Duijvestein M, Vos AC, Roelofs H et al (2010) Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study. Gut.
  25. 25.
    Gao F, Chiu SM, Motan DA et al (2016) Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. Google Scholar
  26. 26.
    Boregowda SV, Krishnappa V, Phinney DG (2016) Isolation of mouse bone marrow mesenchymal stem cells. Methods Mol Biol. Google Scholar
  27. 27.
    Baldari S, Di Rocco G, Piccoli M et al (2017) Challenges and strategies for improving the regenerative effects of mesenchymal stromal cell-based therapies. Int J Mol Sci. Google Scholar
  28. 28.
    Trounson A, Thakar RG, Lomax G, Gibbons D (2011) Clinical trials for stem cell therapies. BMC Med. Google Scholar
  29. 29.
    Da Silva Meirelles L, Nardi NB (2003) Murine marrow-derived mesenchymal stem cell: ISolation, in vitro expansion, and characterization. Br J Haematol. Google Scholar
  30. 30.
    Peister A, Mellad JA, Larson BL et al (2004) Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood. Google Scholar
  31. 31.
    Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. Google Scholar
  32. 32.
    Hsu PJ, Liu KJ, Chao YY et al (2015) Assessment of the immunomodulatory properties of human mesenchymal stem cells (MSCs). J Vis Exp. Google Scholar
  33. 33.
    Ivanova-Todorova E, Bochev I, Dimitrov R et al (2012) Conditioned medium from adipose tissue-derived mesenchymal stem cells induces CD4 + FOXP3 + cells and increases IL-10 secretion. J Biomed Biotechnol. Google Scholar
  34. 34.
    Deng Y, Zhang Y, Ye L et al (2016) Umbilical cord-derived mesenchymal stem cells instruct monocytes towards an IL10-producing phenotype by secreting IL6 and HGF. Sci Rep. Google Scholar
  35. 35.
    Puissant B, Barreau C, Bourin P et al (2016) Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol. Google Scholar
  36. 36.
    Chen PM, Liu KL, Hsu PJ et al (2014) Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2. J Leukoc Biol. Google Scholar
  37. 37.
    Ryan EJ, Bengtsson AK (2002) Immune function of the decoy receptor osteoprotegerin. Crit Rev Immunol 22:15CrossRefGoogle Scholar
  38. 38.
    Fan L, Hu C. Chen J, Cen P et al (2016) Interaction between mesenchymal stem cells and B-cells. Int J Mol Sci. Google Scholar
  39. 39.
    Rosado MM, Bernardo ME, Scarsella M et al (2015) Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells. Stem Cells Dev. Google Scholar
  40. 40.
    Schlesinger M, Rabinowitz R, Levy P, Maayan S (1996) The expression of CD8 on B lymphocytes in HIV-infected individuals. Immunol Lett 50:23–27CrossRefGoogle Scholar
  41. 41.
    Rabinowitz R, Massiah E, Hadar R, Schlesinger M (1995) In vitro activation leads to the binding of T-cell markers to the surface of B-lymphocytes. Clin Immunol Immunopathol 76:148–154CrossRefGoogle Scholar
  42. 42.
    Hu Y, Qin C, Zheng G et al (2016) Mesenchymal stem cell-educated macrophages ameliorate LPS-induced systemic response. Mediators Inflamm. Google Scholar
  43. 43.
    Yin Y, Wu RX, He XT et al (2017) Influences of age-related changes in mesenchymal stem cells on macrophages during in-vitro culture. Stem Cell Res Ther. Google Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  • Marwa El-Sayed
    • 1
    • 2
    Email author return OK on get
  • Mohamed Ali El-Feky
    • 2
    • 3
  • Mostafa I. El-Amir
    • 2
  • Al Shaimaa Hasan
    • 1
    • 4
  • Mohammed Tag-Adeen
    • 5
    • 6
  • Yoshishige Urata
    • 1
  • Shinji Goto
    • 1
  • Lan Luo
    • 1
  • Chen Yan
    • 1
  • Tao-Sheng Li
    • 1
  1. 1.Department of Stem Cell BiologyNagasaki University Graduate School of Biomedical SciencesNagasakiJapan
  2. 2.Department of Microbiology and Immunology, Faculty of MedicineSouth Valley UniversityQenaEgypt
  3. 3.Department of Microbiology and Immunology, Faculty of MedicineAssiut UniversityAssiutEgypt
  4. 4.Department of Pharmacology, Faculty of MedicineSouth Valley UniversityQenaEgypt
  5. 5.Internal Medicine Department, Faculty of MedicineSouth Valley UniversityQenaEgypt
  6. 6.Hepatology and Gastroenterology DepartmentNagasaki University HospitalNagasakiJapan

Personalised recommendations